Ryder Steven has filed 4 insider transactions across 2 companies since February 2024.
Most recent transaction: a grant/award of 16000 shares of MBX Biosciences, Inc. ($MBX) on June 05, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 5, 2025 | MBX Biosciences, Inc. | $MBX | Ryder Steven | Not found | A | Stock option (right to buy) | 16000 | $0.00 | 16,000.0000 | 33,424,371 | 9999.99% | 0.05% |
| Feb. 14, 2025 | Rallybio Corp | $RLYB | Ryder Steven | Chief Medical Officer | A | Option (Right to Buy) | 180000 | $0.00 | 180,000.0000 | 43,544,824 | 9999.99% | 0.41% |
| Sept. 12, 2024 | MBX Biosciences, Inc. | $MBX | Ryder Steven | Not found | A | Stock Option (Right to Buy) | 15963 | $0.00 | 15,963.0000 | 0 | 9999.99% | 0.00% |
| Feb. 15, 2024 | Rallybio Corp | $RLYB | Ryder Steven | Chief Medical Officer | A | Option (Right to Buy) | 120000 | $0.00 | 120,000.0000 | 40,447,388 | 9999.99% | 0.30% |